We developed a mouse model to compare the virulence of Campylobacter fetus strains with (S-plus) and without (Sminus) surface array protein (S-protein) capsules. In adult HA/ICR mice pretreated with ferric chloride, the LDF0 for S-plus strain 84-32 was 43.3 times lower than its spontaneous S-minus mutant 84-54. Seven strains of inbred mice were no more susceptible than the outbred strain. In contrast to the findings with Salmonella typhimurium by others, 3 X 107 CFU of strain 84-32 caused 90% mortality in C3H/HeN (LPS) mice and 40% mortality in C3H/HeJ (LPSd) mice. High-grade bacteremia in HA/ICR mice occurred after oral challenge with S-plus C. fetus strains and continued for at least 2 d, but was not present in any mice challenged with S-minus strains. Bacteremia at 30 min after challenge was 51.6-fold lower in mice pretreated with 10 ul of rabbit antiserum to purified S-protein than after pretreatment with normal rabbit serum. Challenge of mice with a mixture of S-minus strain 84-54 and free S-proteins at a concentration 31.1-fold higher than found in wildtype strain 84-32 caused 30% mortality, compared with 0% with strain 84-54 or S-protein alone. These findings in a mouse model point toward the central role of the S-protein in the pathogenesis of C. fetus infection. The S-protein is not toxic per se, but enhances virulence when present on the bacterial cell surface as a capsule. (J. Clin. Invest. 1990Invest. . 85:1036
Introduction
Campylobacterfetus subspeciesfetus is recognized in humans as an opportunistic pathogen causing systemic infections in immunocompromised hosts (1) (2) (3) (4) . Recent reports indicate that C.fetus also causes diarrhea and suggest that the intestinal tract may be its portal of entry into the bloodstream (5) . Although the mechanisms by which C. fetus causes systemic infection have not been defined, several in vitro studies indicate that a surface array protein (microcapsule) in wild-type C. fetus strains plays a critical role in the organism's ability to resist both the complement-mediated bactericidal activity in normal human serum and phagocytosis by neutrophils (6) (7) (8) . This serum-and phagocytosis-resistance is the probable explanation for the high frequency of extraintestinal infection by C. fetus.
C. fetus cells contain several surface array proteins (S-proteins)' with molecular weights ranging from 100,000 to 149,000 (9) , which form a hexagonal subunit capsular structure on the outer surface of the cell (10) . For a given strain, a single protein usually is predominant (9) . After repeated in vitro passage, some isolates lose these S-proteins and become unencapsulated, without change in other proteins (6, 7) . Previous studies of these unencapsulated mutants showed that loss of these high molecular weight S-proteins was associated with loss of resistance to phagocytosis and normal serum killing (6, 7, 1 1). To date, correlation of these in vitro results with virulence in an animal model has not been demonstrated.
The aim of this study was to establish an animal model for C. fetus infections, and then to determine the importance of the S-proteins in C. fetus virulence. Using a mouse model, we have now been able to: (a) demonstrate that the LDse of a C. fetus wild-type strain is significantly lower than that of its unencapsulated mutant; (b) correlate the presence of S-proteins on C. fetus strains with bacteremia after oral challenge; and (c) determine the relative toxicity of the S-protein.
Methods
Bacterial strains. 14 C. fetus strains from the culture collection of the Denver Veterans Administration Medical Center Campylobacter Laboratory were used in this study. These strains included 12 original isolates from infected humans or animals and two laboratory mutants. The LPS serotyping and the susceptibility of all these strains to the bactericidal activity present in normal human serum had been previously determined (7, 8, 12) . Nine strains contained S-protein, five (84-32, 82-40LP, 84-86, 80-109, and 84-112) were serum resistant (loglo killing < 0.1), and four (84-91, 84-94, 84-107, and 84-108) were serum sensitive (logo killing > 1). Three strains (81-170, 83-88, and 84-90) were wild-type strains lacking S-proteins and were serum sensitive. Strains 84-54 and 82-40HP were spontaneous mutants of 84-32 and 82-40LP that lacked S-proteins and were serum sensitive. All strains were maintained frozen at -70'C in brucella broth (BBL Microbiology Systems, Cockeysville, MD) 
Results
Identification ofS-proteins in C. fetus strains. Our initial animal studies were performed with the paired strains (23D) and 84-54 (23B), the latter being the spontaneous mutant of the former strain (7, 10) . Before use in animals, we confirmed by SDS-PAGE and Western blotting that strain 84-32 possessed the S-protein (S-plus), whereas strain 84-54 (S-minus) did not (Figs. 1 and 2). Also shown in the figure are the SDS-PAGE profiles of the other pair of strains 82-40LP (S-plus) and 82-40HP (S-minus), as well as strains 84-86, 80-109, 84-112, 84-91, 84-94, 84-107, and 84-108 (all S-plus), and 81-170, 83-88, and 84-90 (all S-minus) used in later studies. Western blotting with rabbit antiserum against the 100,000-mol wt S-protein of strain 82-40LP ( Fig. 2) confirmed both that the S-proteins were present in these strains and that all were antigenically related, except for the 127,000-mol wt S-protein on strain 84-94. No such proteins or fragments were recognized in the S-minus strains.
Effect ofpretreatment on susceptibility to peritoneal challenge. Because C. fetus is primarily associated with systemic infection in humans, we first challenged mice with organisms delivered by the parenteral route. The wild-type S-plus strain used in these studies was 84-32. After IP challenge of adult HA/ICR mice with up to I X 1010 live bacteria, no mortality was observed (data not shown). Because iron pretreatment enhances virulence of other bacterial pathogens (19- next sought to determine whether a similar phenomenon existed for C. fetus infection. We found that after pretreatment with either ferric chloride or iron complexed with dextran, intraperitoneally administered strain 84-32 now caused lethality at doses as low as 1 X 107 CFU (Table I) . No mortality was seen in mice treated with iron compounds without bacterial challenge. The enhancement due to ferric chloride treatment was greater than that due to iron dextran. IP challenge was associated with greater lethality than was intravenous chal- lenge (Table II) . Therefore, based on these studies, we used iron pretreatment and IP inoculation for all subsequent parenteral challenges. Effect of mouse strain on susceptibility to IP challenge. Because large numbers of viable C. fetus 84-32 cells were required to kill the outbred HA/ICR mice, we next examined whether inbred mice with defined genetic characteristics might be more susceptible. For six different inbred strains, susceptibility to IP challenge was not measurably different than for HA/ICR mice (Table III) . Previous studies have shown that spleen cells from C3H/HeJ mice do not respond to challenge with bacterial LPS by showing mitogenic or other immune response, whereas the same cells from C3H/HeN mice do respond (24, 25) . After parenteral challenge with Salmonella species, mortality is higher in the C3H/HeJ mice than in C3H/HeN mice (25) . Since C. fetus cells contain LPS with long polysaccharide side-chains (26) , it seemed likely that after IP challenge C3H/HeJ mice should have a worse outcome than C3H/HeN mice (LPS-responder strain). However, we found in repeated experiments that significantly greater mortality occurred in C3H/HeN (LPS-responder strain) than in C3H/HeJ mice (Table IV) (P < 0.001, Yates corrected Chisquared test).
LD5o in outbred mice. In any event, mortality was no greater in C3H/HeN mice than in the outbred HA/ICR mice.
Therefore, all subsequent studies were performed in HA/ICR mice to compare virulence between an S-plus strain and its spontaneous S-minus mutant. For these experiments a total of 240 mice were used, 10 for each bacterial dilution for each condition. As expected, the LD50 for strain 84-32 (S-plus) was 5.8-fold lower after pretreatment with ferric chloride than after iron dextran (Table V) . In both experiments, the LD50 for 84-54 (S-minus) was significantly (15.5-and 43.3-fold) greater than for 84-32 (S-plus). At doses > 109 CFU, both strains produced -100% mortality, whereas differences in mortality were observed at doses < I09 CFU (Fig. 3) . We then examined the time course of mortality after challenge with 3 X 106, 1.5 X 107, 7.5 X 107, 3.8 X 108, and 1.9 X 109 CFU ofstrains 84-32 and 84-54 with 10 mice at each dose for each strain. The cumulative percent survival from low dose (3 X 106) to high dose (1.9 X lO9) for each strain was calculated against time. For both strains, death rarely occurred before 24 h or after 72 h after challenge. Between 24 and 72 h, 29 of 50 mice (58%) infected with strain 84-32 died, compared with 12 of 50 mice (24%) infected with strain 84-54 (P < 0.001, Yates corrected Chi-squared test) (Fig. 4) . Thus, the virulence of the S-plus strain was significantly greater than the S-minus strain in this parenteral challenge model. Oral challenge. Since for humans the presumed route of infection with C.fetus is via oral ingestion, we next studied the effects of oral challenge on the HA/ICR mice. After ferric chloride pretreatment, none of 10 mice orally challenged with S-plus strain 84-32 or with its S-minus mutant 84-54 died during a 5-d period. Since in human infections C. fetus translocates from the intestinal tract to the bloodstream, we asked whether this phenomenon was related to the presence of the S-protein. Blood cultures from each mouse were obtained before and after oral challenge with strain 84-32 or 84-54. No bacteria were isolated from the blood samples taken before challenge. All five mice challenged with 2 X 108 CFU of 84-32 showed high-grade bacteremia at 30 min, 4 h, 24 h, and 48 h C. fetus strain 84-32. Each mouse was pretreated with 10 Al of rabbit antiserum to 100,000-mol wt purified S-protein, normal rabbit serum, or normal saline as controls. Blood cultures were performed on samples taken at 30 min, 4 h, 12 h, and 24 h after oral challenge. Immune serum to the 100,000-mol wt S-protein was highly protective compared with normal rabbit serum and the normal saline control (Fig. 5) . These results support the hypothesis that the S-proteins play an important role in virulence.
Toxicity ofS-protein. A group of 10 mice was intraperitoneally challenged with one of two suspensions of strain 84-54, containing either 6.1-or 31.1-fold more S-protein than found on strain 84-32. As expected, IP injection of 4 X 106-4 X IO0 CFU of S-plus strain 84-32 caused 80% mortality in the ironpretreated mice, whereas S-minus strain 84-54 caused none (Table VIII) . Suspension of strain 84-54 in a solution containing S-proteins at a 6. 1-fold excess over that associated with strain 84-32 caused no mortality, but at a 31.1-fold excess 30% mortality was observed. S-protein alone or strain 84-54 with BSA were administered as controls and were associated with no mortality. To investigate whether the S-proteins are nonspecific virulence factors or only enhance virulence of C. fetus strains, we attempted to attach the S-proteins to Campylobacterjejuni strain 81-176. In the presence of 5 mM CaCl2, the S-protein readily attached to C. fetus strain 84-54 and remained attached as visualized by SDS-PAGE (data not shown) despite three successive washes in Hepes buffer (pH 7.2) with 5 mM CaCl2. In contrast, under the same conditions we could not produce any attachment to the C. jejuni strain. As such, we were unable to perform virulence studies with the combination of S-protein and a non-C. fetus strain of low virulence. These experiments suggest that C. fetus strains may have specific receptors for the S-proteins.
Discussion
The results of this study demonstrate a correlation between the presence of S-proteins and virulence of C. fetus strains. A strain encapsulated with S-proteins has a lower LD50 value for IP challenge in mice than its unencapsulated mutant strain, and encapsulated strains are able to penetrate the gastrointestinal mucosa after oral challenge, causing bacteremia and systemic infection. The IP challenge model could be considered as artificial because of iron pretreatment and high dose of C. fetus. However, C. fetus is an opportunistic pathogen of humans. Most hosts with systemic C. fetus infections are compromised by liver disease, neoplasia, or immunosuppression (7); iron pretreatment serves an analogous function in the experimental model. Similar to humans, normal mice are resistant to C. fetus, even at doses as high as 1010 CFU, but become susceptible after compromise (in this case, iron pretreatment). High dose is necessary because this organism is an opportunistic pathogen that is not as virulent as Salmonella typhi to humans or Salmonella typhimurium to mice. The IP challenge model resembles an endotoxemia model. However, it is a infection model as well, despite lack of direct evidence of replication of organisms in the peritoneal cavity and spread to the reticuloendothelial system. In earlier work we showed a significantly greater increase in splenic size after IP challenge with the Splus strain than the S-minus strain (Blaser, M. J., and D. J. Duncan, unpublished data). In our experiment to protect mice from lethal IP challenge with S-plus strain 84-32, 70% of mice were protected with antiserum to S-protein compared with 30% protected with antiserum to the heat-stable 0 antigen (mostly LPS) of same bacteria (Pei, Z., and M. J. Blaser, unpublished data). In this model, most mice died between 24 and 72 h after challenge, similar to that observed with endotoxemia. A typical endotoxemia model would not differentiate an S-plus strain from an S-minus strain when mice are challenged with the same doses of bacteria and thus LPS (26) ; however, the C. fetus IP challenge model that we used clearly did so.
Iron is essential for the growth of essentially all bacteria (27, 28), and iron overload appears to be a risk factor for systemic C. fetus infection in humans (1) (2) (3) (4) . The growth of pathogenic bacteria in vivo depends on their ability to obtain iron bound by host substances, such as transferrin and lactoferrin (29) (30) (31) (32) . Most aerobic bacteria produce siderophores, high-affinity compounds that bind, solubilize, and transport iron across the cell membrane (33, 34) , but none are produced by Campylobacter species (35). Iron-containing compounds such as mucin, iron dextran, and ferric chloride have been Each mouse was pretreated with 1 mg elemental iron as ferric chloride IP 2 h before oral challenge and checked for bacteremia 4 h after challenge. * LPS serotype determined as described (7, 12) . * Serum killing is expressed in Logl0. Data are from reference 7. 1I Number with bacteremia detected/number receiving that dose.
used to enhance the virulence of Neisseria (20) , Vibrio (21) , Campylobacter (19) , and other species. In the present study, the virulence of C. fetus strains was enhanced at least 100-fold by pretreatment of mice with iron dextran or ferric chloride. Although the mechanisms by which iron compounds increase susceptibility to C.fetus infection were not determined, saturation of transferrin, or impaired murine macrophage function may have been factors (36) (37) (38) (39) . Several lines of evidence suggest that the C.fetus S-proteins are not toxic per se but enhance virulence when present on bacterial cell surfaces as a capsule. (e) Finally, the evidence that these S-proteins are virulence determinants was further strengthened by the passive protection of HA/ICR mice with antiserum to S-protein from highdegree bacteremia after oral challenge. Our previous in vitro work indicates that one of the mechanisms by which the Sprotein capsule protects C. fetus is via its inhibition of C3b binding, preventing immune elimination (1 1).
Oral challenge of mice with C. fetus provides a relevant model for study of human infection. The ability to cause bacteremia after oral challenge was related only to the presence of S-proteins, not to iron pretreatment, LPS type, or the susceptibility of C. fetus strains to killing by normal serum. S-plus C. fetus strains can apparently penetrate the intestinal wall and produce bacteremia lasting 48-120 h after oral challenge. The mechanism for this penetration has not been determined, but it is clearly rapid in onset. Although no illness or mortality was observed as a result of bacteremia, we might expect longerlasting bacteremia, morbidity, and even mortality in orally challenged immunocompromised mice, similar to that observed in compromised humans (1, 3, 4) .
Immunocompromise is a prerequisite for C. fetus to cause systemic infection in humans (1, 3, 4) , suggesting that immune function is highly related to host susceptibility to C. fetus infection. Most S-plus strains are resistant to in vitro killing by normal serum, but exceptions have been noted (7, 8 To find mouse strains more susceptible to C. fetus infection, we compared an outbred and six inbred mouse strains with different H-2, Ity, and LPS-response genes. Susceptibility of mice to C. fetus infection was independent of H-2 and Ity genes. However, by comparing paired LPSd mice (C3H/HeJ) and LPS' mice (C3H/HeN), we found that susceptibility was linked to LPS responsiveness, which is independent of Ity status (22) . C3H/HeJ mice are defective in their response to most biological effects of LPS (41-45) due to a mutation at the LPS gene locus on chromosome 4 (25) . The LD50 of S. typhimurium is < 2 CFU in LPSd C3H/HeJ mice and I03-104 CFU in LPS1 C3H/HeN mice (22) . In contrast to these observations, greater mortality was found in LPS" C3H/HeN mice challenged with S-plus C. fetus than in LPSd C3H/HeJ mice (Table IV) . The LPS gene controls both susceptibility to the toxic effects of LPS and specific and more generalized immunoregulatory responses to LPS (25, (41) (42) (43) (44) (45) . Defects in the LPS gene ofC3H/HeJ mice render them resistant to endotoxic shock after challenge with purified LPS at concentrations that are lethal to other C3H lineages and unresponsive to the immunostimulatory effects of LPS (25, (41) (42) (43) (44) (45) . C. fetus is a pathogen adapted to the bovine and ovine species, and is clearly much less virulent in mice than S. typhimurium with significantly higher LD!,Os even for the more virulent S-plus strain. However, C. fetus LPS has endotoxic activity similar to that of the Enterobacteriaceae (26) . As evidenced by the temporal characteristics of C. fetus-induced lethality, the toxic effects of LPS may be important virulence factors, whereas LPS at the challenge level may have minimal toxic effects in S.
typhimurium-infected mice. In the present study, relative resistance of C3H/HeJ mice to the toxic effects of LPS is the most likely factor responsible for their lower susceptibility than C3H/HeN mice to C. fetus infection.
In conclusion, we have described a mouse model of C.fetus infection that is relevant to human infection. The presence of S-proteins is an important virulence factor after parenteral or oral challenge of these animals. These in vivo studies raise a number of interesting questions relating to the mechanisms by which encapsulated C. fetus strains cause disease, such as the role of iron in C. fetus infection, differences between S-proteins from C. fetus strains with type A LPS or type B LPS, and how S-proteins enable C. fetus to penetrate the intestinal wall and cause systemic infection.
